Acciones Teva Pharmaceutical Industries Ltd (ADR) Nasdaq
Acciones
US8816242098
Farmacéuticos
Ventas 2024 * | 16 mil M 14,68 mil M | Ventas 2025 * | 16,62 mil M 15,25 mil M | Capitalización | 19,34 mil M 17,75 mil M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 809 M 742 M | Resultado Neto 2025 * | 1375 M 1261,66 M | VE / Ventas 2024 * | 2,15 x |
Deuda neta 2024 * | 14,98 mil M 13,75 mil M | Deuda neta 2025 * | 12,44 mil M 11,42 mil M | VE / Ventas 2025 * | 1,91 x |
P/E ratio 2024 * |
17,8
x | P/E ratio 2025 * |
12,2
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 90,93 % |
Último transcript sobre Teva Pharmaceutical Industries Ltd (ADR)
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Kathleen Veit
CMP | Compliance Officer | - | 01/01/10 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+63,05 % | 856 mil M | |
+39,12 % | 631 mil M | |
-4,78 % | 359 mil M | |
+17,52 % | 325 mil M | |
+8,43 % | 297 mil M | |
+13,55 % | 244 mil M | |
+5,32 % | 234 mil M | |
+16,32 % | 226 mil M | |
+14,63 % | 177 mil M |